Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04235686 · ClinicalTrials.gov registry record · Phase 2
8 Week Multi-site Study of MYDAYIS® for Bipolar Depression
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 74
- Enrollment target
NCT04235686: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT04235686 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 74 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04235686, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 74 participants
- Enrollment target
Study Summary
This protocol is a Phase 2 multi-site study which aims to evaluate the safety and effectiveness of MYDAYIS\® as adjunctive therapy for adults with bipolar depression. Results from this study WILL NOT be used to contribute to an approval of MYDAYIS \® for this indication.
Interventions
- DRUG Placebo
- DRUG Mydayis Extended-Release Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2020-07-17 |
| Est. Completion | 2025-07-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04235686
The ClinicalTrials.gov registry entry for NCT04235686 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04235686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04235686 about?
NCT04235686 is a clinical study titled "8 Week Multi-site Study of MYDAYIS® for Bipolar Depression". This protocol is a Phase 2 multi-site study which aims to evaluate the safety and effectiveness of MYDAYIS\® as adjunctive therapy for adults with bipolar depression. Results from this study WILL NOT be used to contribute to an approval of MYDAYIS \® for this indication.
What is the current status of trial NCT04235686?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 74 participants. The study started on 2020-07-17. Estimated completion is 2025-07-25.
What interventions are being tested in trial NCT04235686?
The interventions under investigation include: Placebo (DRUG), Mydayis Extended-Release Capsule (DRUG).
Who is sponsoring clinical trial NCT04235686?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.